ASCEND BY NTHRYS
Research Abroad Products

Cancer Systems Biology Project Topics

Browse all focused areas across all project categories under this field.

Showing 61–72 of 200 project topics
Glucose Uptake Inhibitor Screening Platform SaaS
A cloud-based high-throughput screening platform that identifies and optimizes GLUT1/GLUT3 inhibitor compounds targeting cancer cell glucose dependency. The platform enables pharma companies to reduce drug discovery timelines by 40% and accelerate lead compound validation for metabolic oncology pipelines.
Cancer Metabolic Reprogramming Drug Targets Click to view more details →
Lactate Metabolism Biomarker Discovery Software Suite
An AI-powered diagnostic software tool that predicts lactate-dependent tumor subtypes and identifies patients most responsive to monocarboxylate transporter inhibitors. This enables precision oncology companies to develop companion diagnostics generating recurring SaaS licensing revenue and improved clinical trial enrollment.
Cancer Metabolic Reprogramming Drug Targets Click to view more details →
Lipid Biosynthesis Enzyme Inhibitor Development Toolkit
A comprehensive computational and experimental toolkit targeting FASN, ACLY, and SCD1 pathways in cancer cells with pre-validated assay protocols. Biotech firms can license this modular platform to accelerate fatty acid metabolism drug development and reduce R&D costs by 30%.
Cancer Metabolic Reprogramming Drug Targets Click to view more details →
Glutamine Addiction Profiling and Drug Matching Engine
A machine learning platform that analyzes tumor glutamine dependency profiles and matches patients to optimal GLS/ASCT2 inhibitor therapies in real-time. Clinical centers and biopharma companies generate per-test revenue while improving patient response rates and treatment personalization.
Cancer Metabolic Reprogramming Drug Targets Click to view more details →
Mitochondrial OXPHOS Targeting Compound Library Management System
A digital platform managing proprietary compound libraries targeting complex I/III inhibitors and ATP synthase blockers with automated activity tracking. This SaaS solution streamlines in-house drug discovery operations and enables licensing to contract research organizations seeking metabolic oncology expertise.
Cancer Metabolic Reprogramming Drug Targets Click to view more details →
Pentose Phosphate Pathway Flux Analysis and Optimization Tool
An integrated bioinformatics platform quantifying G6PD and transketolase pathway flux from patient tumors and predicting G6PD inhibitor sensitivity. Diagnostic companies monetize through subscription-based tumor profiling services offering actionable metabolic data to oncologists and pharmaceutical researchers.
Cancer Metabolic Reprogramming Drug Targets Click to view more details →
Serine and One-carbon Metabolism Drug Target Platform
A specialized discovery platform targeting PHGDH, SHMT2, and folate metabolism enzymes with integrated high-content screening capabilities. Biotech developers license this platform to reduce lead optimization timelines and establish competitive advantages in the emerging one-carbon metabolism oncology market.
Cancer Metabolic Reprogramming Drug Targets Click to view more details →
Tumor Microenvironment Metabolic Competition Modeling Software
A computational platform simulating metabolic crosstalk between cancer cells, immune cells, and fibroblasts to identify combination drug targets. Healthcare organizations and CROs license this to design superior combination therapies and improve clinical trial success rates in immuno-oncology programs.
Cancer Metabolic Reprogramming Drug Targets Click to view more details →
Hypoxia-Inducible Factor HIF Stabilizer Screening Service
A contract research service providing HIF-1α/2α stabilizer compound screening, validation, and off-target profiling for hypoxia-adaptive metabolism targeting. Service revenues scale with client project volumes while building proprietary data on metabolism-immune nexus in solid tumors.
Cancer Metabolic Reprogramming Drug Targets Click to view more details →
Metabolic Vulnerability Index Clinical Decision Support System
An FDA-compliant clinical software system that generates patient-specific metabolic vulnerability scores from omics data and recommends targeted metabolic therapies. Healthcare systems deploy this as a premium SaaS solution to improve treatment outcomes and capture ancillary service fees from integrated metabolic testing.
Cancer Metabolic Reprogramming Drug Targets Click to view more details →
Checkpoint Inhibitor Response Prediction Engine SaaS
A cloud-based platform that analyzes tumor microenvironment data to predict patient response to PD-1/PD-L1 and CTLA-4 checkpoint inhibitors before treatment initiation. This enables oncology practices to improve treatment selection accuracy, reduce failed therapies, and optimize reimbursement rates by 30-40% through precision dosing recommendations.
Tumor Immune Evasion Systems Analytics Platforms Click to view more details →
Immunosuppressive Tumor Microenvironment Profiling Software Suite
An integrated diagnostic software platform that quantifies immunosuppressive cell populations, cytokine signatures, and metabolic barriers within tumor tissue samples using multimodal data integration. This delivers actionable insights for clinical decision-making while creating recurring SaaS licensing revenue and companion diagnostic partnerships with pharmaceutical companies.
Tumor Immune Evasion Systems Analytics Platforms Click to view more details →